Abstract
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Author(s): Snyder Scott, Listecki Robert E
Issue: Sep/Oct 2012 - Volume 16, Number 5
Page(s): 376-380
Note: Electronic version includes supplemental material.
Abstract
Effective thyroid replacement therapy may be elusive to some patients, and compounding pharmacists have an opportunity to deliver more effective therapy. Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th edition states that the body usually secretes T4:T3 in an 11:1 ratio but cautions against pursuing combined thyroid replacement due to the short halflife of T3 that necessitates multiple daily dosing; no commercial availability and lack of benefit were shown in trials.1 Commercial combinations of T4/T3 such as Armour Thyroid and Nature-Thyroid have a 4.22:1 T4:T3 ratio. Applying the same concept as bioidentical hormone replacement therapy, compounding pharmacists can deliver an 11:1 ratio using a commercial T4 product and taking into account oral bioavailability of each entity. The short half-life of T3 can be remedied by taking the patient’s daily T3 dose and dividing it into two slow-release capsules to be dosed every 12 hours.
Related Keywords
- thyroid hormone deficiency
- hypothyroidism
- thyroid replacement
- oral bioavailability
- slow-release preparation
- literature review
- combination T4/T3 therapy
- formulation
- levothyroxine
- T4
- liothyronine
- T3
Related Categories
- FORMULATIONS
- HRT
- ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
- LITERATURE REVIEW
- PATIENT ASSESSMENT
Related Articles from IJPC
Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
---|---|
Sep/Oct 2012
Pg. 376-380
|
Author(s):
Snyder Scott, Listecki Robert E
|
Jul/Aug 2005
Pg. 268-273
|
Author(s):
Milner Martin
|
Sep/Oct 2017
Pg. 418-425
|
|
Nov/Dec 2008
Pg. 545
|
Author(s):
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 306-309
|
Author(s):
Stack Bob
|
Jan/Feb 2023
Pg. 22-23
|
Author(s):
Brunner Scott
|
Mar/Apr 2010
Pg. 165-170
|
|
Nov/Dec 2008
Pg. 547
|
Author(s):
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 548
|
Author(s):
Allen Loyd V Jr
|
Jul/Aug 2003
Pg. 250-256
|
Author(s):
Gillson George R, Zava David T
|
Jan/Feb 2002
Pg. 50-54
|
Author(s):
Wepfer Scott T
|
Nov/Dec 2008
Pg. 488-497
|
Author(s):
Paoletti Jim
|
Jan/Feb 2024
Pg. 34-43
|
Author(s):
Paoletti Jim
|
Jan/Feb 2001
Pg. 52-54
|
Author(s):
Ford Gina, Garcia Lea
|
Mar/Apr 2002
Pg. 142-146
|
Author(s):
Wepfer Scott T
|
Jul/Aug 2004
Pg. 313-319
|
|
Jul/Aug 2005
Pg. 266
|
Author(s):
White Irene Q
|
Nov/Dec 2016
Pg. 447-454
|
Author(s):
Deleruyelle Laura J
|
Sep/Oct 2016
Pg. 359-364
|
Author(s):
Deleruyelle Laura J
|
Jul/Aug 2011
Pg. 290-300
|